Morpholino

MO1-clvs2

ID

ZDB-MRPHLNO-230929-1

Name

MO1-clvs2

Previous Names

None

Target

Sequence

5' - GGCCTGCCTGTAAATGAGTCATTGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-clvs2

No data available

Phenotype

Phenotype resulting from MO1-clvs2

Phenotype	Fish	Figures
eye edematous, abnormal	WT + MO1-clvs2	Figure 2 from Lane et al., 2021
pericardium edematous, abnormal	WT + MO1-clvs2	Figure 2 from Lane et al., 2021
pronephric glomerular basement membrane structure, abnormal	WT + MO1-clvs2	Figure 2 from Lane et al., 2021
pronephric podocyte podocyte foot decreased thickness, abnormal	WT + MO1-clvs2	Figure 2 from Lane et al., 2021
pronephric podocyte podocyte foot shortened, abnormal	WT + MO1-clvs2	Figure 2 from Lane et al., 2021

Phenotype of all Fish created by or utilizing MO1-clvs2

Phenotype	Fish	Conditions	Figures
pericardium edematous, abnormal	WT + MO1-clvs2	control	Figure 2 from Lane et al., 2021
pronephric podocyte podocyte foot shortened, abnormal	WT + MO1-clvs2	control	Figure 2 from Lane et al., 2021
pronephric podocyte podocyte foot decreased thickness, abnormal	WT + MO1-clvs2	control	Figure 2 from Lane et al., 2021
pronephric glomerular basement membrane structure, abnormal	WT + MO1-clvs2	control	Figure 2 from Lane et al., 2021
eye edematous, abnormal	WT + MO1-clvs2	control	Figure 2 from Lane et al., 2021
renal filtration decreased process quality, abnormal	mi1000Tg + MO1-clvs2	control	Figure 2 from Lane et al., 2021

Citations